Stuyvesant Capital Management’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-27,420
| Closed | -$1.62M | – | 33 |
|
|
2017
Q2 | $1.62M | Buy |
27,420
+600
| +2% | +$35.4K | 3.19% | 16 |
|
|
2017
Q1 | $1.48M | Buy |
26,820
+3,000
| +13% | +$165K | 3.12% | 15 |
|
|
2016
Q4 | $1.25M | Sell |
23,820
-3,540
| -13% | -$186K | 2.69% | 17 |
|
|
2016
Q3 | $1.57M | Hold |
27,360
| – | – | 3.65% | 15 |
|
|
2016
Q2 | $1.6M | Buy |
27,360
+125
| +0.5% | +$7.33K | 3.17% | 17 |
|
|
2016
Q1 | $1.57M | Sell |
27,235
-1,015
| -4% | -$58.4K | 3.45% | 15 |
|
|
2015
Q4 | $1.85M | Hold |
28,250
| – | – | 4.64% | 12 |
|
|
2015
Q3 | $1.78M | Sell |
28,250
-3,150
| -10% | -$198K | 4.49% | 11 |
|
|
2015
Q2 | $2.22M | Buy |
31,400
+900
| +3% | +$63.7K | 4.85% | 10 |
|
|
2015
Q1 | $2.14M | Buy |
+30,500
| New | +$2.14M | 4.88% | 8 |
|